- Home
- SPCE vs LYEL Comparison
SPCE vs LYEL Comparison
Compare SPCE & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCE
- LYEL
- Stock Information
- Founded
- SPCE 2017
- LYEL 2018
- Country
- SPCE United States
- LYEL United States
- Employees
- SPCE N/A
- LYEL N/A
- Industry
- SPCE Transportation Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- SPCE Consumer Discretionary
- LYEL Health Care
- Exchange
- SPCE Nasdaq
- LYEL Nasdaq
- Market Cap
- SPCE 226.9M
- LYEL 253.2M
- IPO Year
- SPCE N/A
- LYEL 2021
- Fundamental
- Price
- SPCE $3.58
- LYEL $16.55
- Analyst Decision
- SPCE Hold
- LYEL Hold
- Analyst Count
- SPCE 5
- LYEL 3
- Target Price
- SPCE $10.60
- LYEL $16.67
- AVG Volume (30 Days)
- SPCE 5.4M
- LYEL 26.5K
- Earning Date
- SPCE 11-13-2025
- LYEL 11-12-2025
- Dividend Yield
- SPCE N/A
- LYEL N/A
- EPS Growth
- SPCE N/A
- LYEL N/A
- EPS
- SPCE N/A
- LYEL N/A
- Revenue
- SPCE $1,698,000.00
- LYEL $60,000.00
- Revenue This Year
- SPCE N/A
- LYEL N/A
- Revenue Next Year
- SPCE $2,908.26
- LYEL N/A
- P/E Ratio
- SPCE N/A
- LYEL N/A
- Revenue Growth
- SPCE N/A
- LYEL 11.11
- 52 Week Low
- SPCE $2.18
- LYEL $7.65
- 52 Week High
- SPCE $8.19
- LYEL $30.00
- Technical
- Relative Strength Index (RSI)
- SPCE 41.66
- LYEL 51.84
- Support Level
- SPCE $3.54
- LYEL $15.94
- Resistance Level
- SPCE $4.20
- LYEL $17.24
- Average True Range (ATR)
- SPCE 0.31
- LYEL 0.92
- MACD
- SPCE -0.08
- LYEL -0.27
- Stochastic Oscillator
- SPCE 2.07
- LYEL 22.93
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.